Relapses in the treatment of genotype 2 viral hepatitis C, a cause of concern in the blacks

Indian Journal of Gastroenterology

Volumn 33, Issue 3, 2014, Pages 292-

  Njoya, O ^a   Ntchama, L ^a   Tagni, M ^a   Dang, I ^a   Kowo, M ^a  

^a Department Gastroenterology Réseau Camerounais de Lutte Contre Hépatite Virales ^*  (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A PLUS RIBAVIRIN;

BLACK PERSON; CLINICAL EVALUATION; DISEASE ASSOCIATION; GENOTYPE; HEPATITIS C; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PUBLIC HEALTH; TREATMENT RESPONSE; ADULT; AGED; CAMEROON; EPIDEMIOLOGY; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; PREVALENCE; RECURRENT DISEASE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CAMEROON; FEMALE; GENOTYPE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RECURRENCE;

EID: 84901022072     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-013-0385-3     Document Type: Letter

References (3)

1. Njouom R, Pasquier C, Ayouba A, et al. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of rain forest of south Cameroon. J Med Virol. 2003;71: 219-25.
2. Hézode C, Pawlotsky JM, Dhumeaux D. Traitement de l'hépatite chronique C. In: Pawlotsky JM, Dhumeaux D, (eds). Hépatite C. Paris: EDK; 2004. p. 206-25.
3. Njouom R, Sartre MT, Timba I, et al. Efficacy and safety of peg interferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C. J Med Virol. 2008;80: 2079-85.